Advertisement
News
Advertisement

Cook Medical Remains Resolute in Pursuit of Infringement Action Against Endologix Following Markman Ruling

Mon, 08/22/2011 - 5:46am
BLOOMINGTON, Ind.--(BUSINESS WIRE)--Cook Incorporated, a global leader in endovascular technologies, announced today that Judge Tanya Walton Pratt of the United States District Court for the Southern District of Indiana in Indianapolis has issued a Markman ruling in the ongoing patent infringement lawsuit filed against Endologix (Nasdaq: ELGX). The majority of constructions adopted by the Judge favored Cooks proposed constructions.

"Expandable Transluminal Graft Prosthesis for Repair of Aneurysm"

"Cook has never wavered in the protection of its extensive patent portfolio," said Cook general counsel Cynthia Kretz. "We will move forward as swiftly as possible to obtain all available remedies based on Endologix infringement of our two patents."

The two patents in suit are Cook's U.S. Patent 5,755,777 and 5,035,706. The '777 Patent "Expandable Transluminal Graft Prosthesis for Repair of Aneurysm" was granted on May 26, 1998. The '706 Patent "Percutaneous Stent and Method of Retrieval Thereof" was granted on July 30, 1991.

About Cook Medical

Founded in 1963, Cook Medical pioneered many of the medical devices now commonly used to perform minimally invasive medical procedures throughout the body. Today, the company integrates medical devices, drugs and biologic grafts to enhance patient safety and improve clinical outcomes. Since its inception, Cook has operated as a family-held private corporation. For more information, visit www.cookmedical.com. Follow Cook Medical on Twitter @CookMedicalPR.

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading